https://ift.tt/2IVHF6y

The US Food and Drug Administration issued Form 483 with 14 observations to the company following the completion of inspection from November 4-14.

from Markets https://ift.tt/2QhABUh

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads